Tuesday, October 26

Daily News Day 3 Annual Meeting coverage continues with Plenary recaps and abstract commentaries, a preview of today’s Keynotes, Journals articles featuring Annual Meeting content and more!

Tuesday/Wednesday Show Daily Access the Tuesday/Wednesday Show Daily at the ASTRO Annual Meeting.
Digital Daily October 26, 2021 Access the Digital Daily from day 3 at the ASTRO Annual Meeting.
NRG Oncology/RTOG 0815 NRG/RTOG 0815 demonstrates that short-term ADT improves metastasis-free survival in men receiving dose-escalated radiation therapy with intermediate-risk prostate cancer.
NRG GU003 Hypofractionation is the preferred treatment type of radiation therapy for intact prostate cancer: Is it now also for post-prostatectomy RT based on NRG GU003?
4-D CT-ventilation Functional Avoidance Results of a multi-institutional phase II clinical trial for 4-D CT-ventilation functional avoidance thoracic radiotherapy.
Nasopharyngeal Carcinoma Phase II study investigates the potential of ADC as a predictive MRI biomarker for radiation treatment efficacy for nasopharyngeal concurrent chemo/RT.
RADIOPARP Phase I Trial RADIOPARP phase I trial evaluating olaparib with radiation therapy for triple negative breast cancer demonstrates acceptable toxicity profile with zero grade 3+ adverse events.
Cancer Support Center One of the 2021 ASTRO Survivor Circle Grant reciepients, the CSC serves anyone seeking oncology care and focuses on a health equity initiative providing services to communities of color with high cancer morbidity rates.
LivingWell Cancer Resource Center One of the 2021 ASTRO Survivor Circle Grant recipients, LWCRC is a free oncology support center that provides services to empower people facing cancer with knowledge, strengthened by action and sustained by the supportive LivingWell community. 

American Society for Radiation Oncology
251 18th Street South, 8th Floor
Arlington, VA 22202
Telephone: 703-502-1550


Connect With Us: